BD is releasing its new Nano pen needle designed for achieving consistent depth during subcutaneous injections, particularly for diabetic patients on insulin. Intramuscular injections can occur when a ...

CROSSJECT’s ZENEO® needle-free auto-injector consistently matches depth of traditional intramuscular injections and exceeds the standards needle length of currently utilized auto-injectors Injection ...

BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the launch in the UK and Ireland of BD Micro-Fine Ultra™ with 5-bevel needle technology, clinically ...

Reimbursements and technological development in injection pen to boost adoption. An increased preference for injectable pens over the traditional vial and needle approach, which is being driven by an ...

Insulin pen needles are intended for single use only but it is known that a significant proportion of people with diabetes do re-use needles. People with diabetes ultimately have the choice of whether ...

Injection depth with ZENEO® matches that of 30-mm conventional intramuscular needles, out-performs length of needles imbedded in commercially available needle-based auto-injectors. ZENEO® further ...

CROSSJECT's ZENEO® needle-free auto-injector consistently matches depth of traditional intramuscular injections and exceeds the standards needle length of currently utilized auto-injectors Injection ...